Arcutis Biotherapeutics, Inc.

SEC 4 · Filed

0001798679-26-000002Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date May 4, 2026

Sale by Matsuda Masaru

Security
Common Stock
Code
S
Shares
884
Price per share
23.61Reported 23.6106
Structured facts
{
  "code": "S",
  "date": "2026-05-04",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F4": "The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units.",
    "F5": "The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.16 to $23.93, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."
  },
  "owners": [
    {
      "cik": "0001798679",
      "name": "Matsuda Masaru",
      "roles": [
        "officer"
      ],
      "title": "See Remarks"
    }
  ],
  "ownership": "D",
  "post_shares": "126689",
  "price": "23.6106",
  "row": 2,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "884",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date May 4, 2026

Sale by Matsuda Masaru

Security
Common Stock
Code
S
Shares
7,372
Price per share
23.27Reported 23.2696
Structured facts
{
  "code": "S",
  "date": "2026-05-04",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "The transaction reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted on June 5, 2025, by the Reporting Person, with a plan end date of September 4, 2026.",
    "F2": "The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $23.1167 to $23.48, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.",
    "F3": "Due to a scrivener\u0027s error on the Reporting Person\u0027s Form 4 filed on March 3, 2026, the number of shares of common stock beneficially owned by the Reporting Person reflected a discrepancy that inadvertently overstated the Reporting Person\u0027s beneficial ownership by 1,987 shares. The correct number of shares beneficially owned by the Reporting Person is reflected in this Form 4."
  },
  "owners": [
    {
      "cik": "0001798679",
      "name": "Matsuda Masaru",
      "roles": [
        "officer"
      ],
      "title": "See Remarks"
    }
  ],
  "ownership": "D",
  "post_shares": "127573",
  "price": "23.2696",
  "row": 1,
  "rule_10b5_1": "1",
  "security": "Common Stock",
  "shares": "7372",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}